Propanc Biopharma (PPCB) Other financing activities (2016 - 2025)
Propanc Biopharma (PPCB) posted quarterly Other financing activities of $15000.0 for Q3 2025, down 44.82% quarter-over-quarter from $27182.0 in Q1 2024.
Propanc Biopharma (PPCB) Other financing activities (2016 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Other financing activities for 9 consecutive years, with $15000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Other financing activities changed N/A year-over-year to $15000.0; the TTM figure through Sep 2025 stood at $158467.0 (changed N/A YoY), while the FY2025 annual figure was $264656.0, changed N/A from the prior year.
- Other financing activities slipped to $15000.0 in Q3 2025 per PPCB's latest filing, from $27182.0 in the prior quarter.
- Across five years, Other financing activities topped out at $325000.0 in Q1 2021 and bottomed at $2663.0 in Q4 2023.
- Historically, Other financing activities has averaged $127574.5 across 5 years, with a median of $100000.0 in 2021.
- Annual changes were most pronounced in 2021 — Other financing activities surged 36.79% — and 2023, when it tumbled 97.34%.
- Propanc Biopharma's Other financing activities stood at $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022, then sank by 97.34% to $2663.0 in 2023, then jumped by 920.73% to $27182.0 in 2024, then tumbled by 44.82% to $15000.0 in 2025.
- Business Quant data shows PPCB's Other financing activities at $15000.0 in Q3 2025, $27182.0 in Q1 2024, and $2663.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 15,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Mar 31, 2024 | 27,182.00 |
| Mar 31, 2024 | 27,182.00 |
| Dec 31, 2023 | 2,663.00 |
| Dec 31, 2023 | 2,663.00 |
| Sep 30, 2023 | 113,622.00 |
| Sep 30, 2023 | 113,622.00 |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 150,001.00 |
| Jun 30, 2022 | 150,001.00 |
| Mar 31, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |